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Abstract
Plac8 belongs to an evolutionary conserved family of proteins, mostly abundant in plants where they control fruit weight
through regulation of cell number. In mice, Plac8 is expressed both in white and brown adipose tissues and we previously
showed that Plac82/2 mice develop late-onset obesity, with abnormal brown fat differentiation and reduced thermogenic
capacity. We also showed that in brown adipocytes, Plac8 is an upstream regulator of C/EBPb expression. Here, we first
assessed the role of Plac8 in white adipogenesis in vitro. We show that Plac8 is induced early after induction of 3T3-L1
adipocytes differentiation, a process that is prevented by Plac8 knockdown; similarly, embryonic fibroblasts obtained from
Plac8 knockout mice failed to form adipocytes upon stimulation of differentiation. Knockdown of Plac8 in 3T3-L1 was
associated with reduced expression of C/EBPb, Krox20, and Klf4, early regulators of the white adipogenic program, and we
show that Plac8 could transactivate the C/EBPb promoter. In vivo, we show that absence of Plac8 led to increased white fat
mass with enlarged adipocytes but reduced total number of adipocytes. Finally, even though Plac82/2 mice showed
impaired thermogenesis due to brown fat dysfunction, this was not associated with changes in glycemia or plasma free
fatty acid and triglyceride levels. Collectively, these data indicate that Plac8 is an upstream regulator of C/EBPb required for
adipogenesis in vitro. However, in vivo, Plac8 is dispensable for the differentiation of white adipocytes with preserved fat
storage capacity but is required for normal fat cell number regulation.
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Introduction
Adipogenesis is the process by which fibroblastic-like preadipo-
cytes differentiate into adipocytes capable of storing fat in the form
of triglycerides [1,2]. In vivo, white adipocytes store triglycerides in
a single large lipid droplet from which free fatty acids can be
released during the fasted state and secreted in the blood to
provide metabolic energy to other tissues, such as muscle and liver.
Imbalance between fat storage and release by adipocytes may lead
to gain or loss of body weight. In obesity, excess fat storage and
adipocyte enlargement are often associated with local inflamma-
tion and insulin resistance, production of cytokines, which can
propagate insulin resistance to other tissues, and exaggerated
lipolysis causing storage of fat in liver, muscles, or pancreatic beta-
cells [3,4,5].
Understanding the molecular pathways controlling adipocytes
differentiation from precursor cells is therefore important as this
knowledge may help control adipocyte number and fat mass. A
large body of research has identified a transcriptional cascade
regulating white and brown fat differentiation. Common mech-
anisms controlling the differentiation of both types of fat tissues
include activation of the CAAT/Enhancer Binding Protein ß (C/
EBPb), which activates C/EBPa and C/EBPd; these transcription
factors then stimulate expression of peroxisome proliferator-
activated receptor c (PPARc) [1,2,6]. In white adipocytes, the
transcription factors Krox20 and Klf4 are upstream regulators of
C/EBPb [7,8] whereas brown fat-specific differentiation requires
the interaction of C/EBPb with the zinc finger-containing protein
PRDM16, which leads to adipogenic development through
induction of PPARc and mitochondrial biogenesis through
subsequent activation of peroxisome proliferator-activated recep-
tor c-coactivator 1a (PGC-1a). Whereas genetic inactivation of
PPARc prevents adipocyte development, inactivation of C/EBPb
is still compatible with both white and brown adipose tissue
development but prevents normal function of brown fat [6,9].
In a recent study we identified Plac8, also called onzin, as a novel
upstream regulator of the brown adipocyte differentiation
program. Plac8, a 124 amino acid long protein, shows structural
similarity with the product of the fruit weight 2.2 (fw2.2) gene, which
controls fruit weight in tomato, through a regulation of cell
number. In plants there are many fw2.2-related genes whereas in
mammals Plac8 appears to be the unique member of this family
[10]. Plac8 contains a cysteine-rich sequence located between
amino acids 23–66 (the Plac8 domain). We showed in a recent
report that upon induction of brown preadipocyte differentiation
Plac8 transiently interacts with C/EBPb. The Plac8/C/EBPb
complex then binds to tandem C/EBPb binding sites present on
the C/EBPb gene promoter to induce this gene transcription.
Interaction of Plac8 with C/EBPb requires the initial part of the
cysteine-rich region (a.a. 28–38) and Plac8 deletion mutants
lacking this sequence can no longer rescue the differentiation of
Plac82/2 brown preadipocytes. Plac82/2 mice have abnormal
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brown adipocytes characterized by a single large lipid droplet and
impaired thermogenesis leading to lower body temperature and
cold intolerance [11]. Over time, these mice develop obesity for
reasons that may be related to defects in thermogenesis and,
because Plac8 is also expressed in white adipocyte, to a defect in
this tissue homeostasis.
Therefore, here, we investigated the impact of Plac8 inactivation
on white adipocyte differentiation in vitro and on white adipose
tissue in Plac82/2 mice. We show that Plac8 is required for in vitro
adipogenesis through a regulation of C/EBPb expression and in
vivo it is dispensable for white fat depots production but is required
to properly control white fat mass.
Material and Methods
Mice
Plac82/2 mice on a pure C57Bl/6 background were obtained
from Dr Koller’s laboratory (University of North Carolina) [12].
C57Bl/6 and Plac82/2 mice were crossed to obtain Plac8+/2, and
then Plac8+/2 mice were crossed to obtain Plac8+/+,, Plac8+/2 and
Plac82/2 littermates. Mice were maintained at 24uC on a 12 h/
12 h light/dark cycle (7:00–19:00 h), with free access to water and
standard chow diet (nu 3436 from Provimi Kliba AG, Kaiseraugst,
Switzerland) and were used when 24–29 weeks old when the
obesity was established. All animal studies were approved by the
Veterinary Office of Canton de Vaud, Switzerland.
Glucose, free fatty acids and triglycerides measurements
Blood samples were obtained from retroorbital bleeding in fed
state or after a 16-hour overnight fasting in 24-weeks-old male
mice. Analyses were performed using the Roche/Hitachi Robot
902 (Roche Diagnostics) and Roche kits (Roche, Basel, Switzer-
land).
Histology and morphometry
Visceral and subcutaneous adipose tissues from 29-weeks-old
male mice were embedded in paraffin and 5 mm sections were
prepared for hematoxylin and eosin staining. Hematoxylin-eosin
images from subcutaneous and visceral adipose tissues were used
for morphometric analysis using the AxioVision 4.0 software
(Zeiss, Oberkochen, Germany). 100 cells were measured using the
software per animals.
RNA extraction and real-time PCR
Total RNA was prepared from white adipose tissues from 29-
weeks-old male mice or cultured cells using peqGOLD TriFast
reagent according to the manufacturer’s instructions (Axonlab,
Baden, Switzerland). First strand cDNA was synthesized from
0.5 mg of total RNA using random primers (Promega, Mannheim,
Germany) and Superscript II RNase H- (Invitrogen, Carlsbad,
CA). Real time PCR was performed using Power SYBR Green
Master Mix (Applied Biosystem, Foster City, CA, USA). Specific
mouse primers for each gene were used and are described in Table
S1. All reactions were normalized to cyclophilin levels and
performed in triplicate.
Cells protein extraction and Western blot analysis
Cells were lysed using a RIPA buffer containing SDS 0.1% and
protease inhibitors (Roche, Basel, Switzerland). Western blot
analysis was performed as previously described [13]. 20 mg of
total protein were loaded on a 12% SDS-PAGE for each sample.
Rabbit anti-Plac8 antibody was obtained from Dr. Koller’s
laboratory [12] and used at a dilution of 1/2500, rabbit anti-a-
actin (Sigma, A2066, St-Louis, MO) and peroxidase conjugated
anti-rabbit IgG (Amersham, NA934V, Glattbrugg, Switzerland)
were used as secondary antibodies at a dilution of 1/1000.
SuperSignalR West Pico Stable Peroxide solution (Pierce,
1859674, Rockford, IL) was used for chemiluminescent detection.
Generation of retroviral constructs and retroviral
transductions
Plac8 cDNA was inserted in pMSCV retroviral vectors
(Clontech, Mountain View, CA) with puromycin or hygromycin
selection markers. C/EBPb pMSCV retroviral construct was
kindly provided by Dr. Kivanc Birsoy (Massachussets Institute of
Technology, MA). Viral constructs were transfected using the
calcium-phosphate protocol previously described [14] into Phoe-
nix packaging cells (Pr. G. Nolan, Standford) along with constructs
encoding gag-pol and the VSV-G protein and supernatants were
harvested after 48 h in presence of 3 mM of trichostatin A (Sigma,
St-Louis, MO) and either used immediately or snap frozen and
stored at 280uC for later use. Viral supernatants were added to
the cells for 6 hours in the presence of Polybrene (8 mg/ml,
Sigma, St-Louis, MO), and then diluted twice with fresh medium.
Next day, the viral supernatant was removed and replaced by fresh
medium. Each transduction experiment was repeated three times.
MEF preparation and Cell culture
Mouse embryonic fibroblasts were isolated from Plac8+/+,
Plac8+/2 and Plac82/2 day 14 embryos using the following
protocol. Whole embryos was sliced in small pieces and incubated
at 37uC for 1 hours in ES trypsin buffer (2.5 mg trypsin, 0.4 mg
EDTA, 7 g NaCl, 0.3 mg Na2HP04, 0.24 mg KH2PO4, 0.37 mg
KCl, 1 mg dextrose, 3 mg Tris and 1 ml Difco phenol Red,
pH 7.6). Then add 4 ml of DMEM (Gibco, Carlsbad, CA) with
10% FBS (Gibco, Carlsbad, CA,) and mixed the digested embryos.
Add another 15 ml of medium and incubate the dispersed cells in
a T75 flask. After 48 hours, split the cells to two T175 flasks. The
primary mouse embryonic fibroblast can be used until passage 8–
9. MEF and 3T3-L1 cell line (ATCC, http://www.lgcstandards-
atcc.org/) were cultured in DMEM supplemented with FBS at 5%
CO2. Cells were allowed to grow to confluence in either 100-mm
or 60-mm dishes in DMEM with 10% FBS. Once confluence was
reached, cells were exposed to differentiation medium containing
dexamethasone (1 mM), insulin (5 mg/ml), isobutylmethyl-
xanthine (0.5 mM). After 2 days cells were maintained in medium
containing insulin (5 mg/ml). Medium was changed every other
day. Full differentiation was achieved after 7 days.
Oil red O staining
After 7 to 10 days of differentiation, cells were washed once in
PBS and fixed with formaldehyde (Formalde-fresh; Fisher,
Waltham, MA) for 15 minutes. The staining solution was prepared
by dissolving 0.5 g oil-red-O (Sigma, St-Louis, MO) in 100 ml of
isopropanol; 60 ml of this solution was mixed with 40 ml of
distilled water. After 1 hour at room temperature the staining
solution was filtered and added to dishes for 4 hours. The staining
solution was then removed and cells were washed twice with
distilled water.
Trans-activation assays
The 3 kb C/EPBb promoter in pGL3 plasmid was a gift from
Dr Kivanc Birsoy (Boston, MA). The pMSCV retroviral plasmid
for Plac8 was used as expression vector. The 1.3 kb Krox20
promoter was obtained from Addgene (http://www.addgene.org/
). 3T3-L1 preadipocytes cell line were transfected at 80%
confluence using LipofectamineTM LTX Reagent (Invitrogen,
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Carlsbad, CA) as per the manufacturer’s protocol. A ß-
galactosidase expression vector was co-transfected into cells as a
control for transfection efficiency. Luciferase and ß-galactosidase
activity were assessed 2 days after differentiation using the
Galacto-Star luciferase reporter assay (Roche, Basel, Switzerland)
following the manufacturer’s instructions. Transfections were
performed in triplicate and repeated three times. Statistics were
performed using the Student t-test.
shRNA constructs
shRNAs were constructed using the pSIREN RetroQ vector
(Clontech, Mountain View, CA). Two different target sequences
for Plac8 were designed by querying the Whitehead siRNA
algorithm (http://jura.wi.mit.edu/bioc/siRNAext/) as well as the
siRNA designer software from Clontech (http://bioinfo.clontech.
com/rnaidesigner/). The sequences chosen for Plac8 were
TCGTGACTCAACCTGGATT and ACGGCATTCCTG-
GATCTAT. Retroviral production, transduction of 3T3-L1 cell
line and differentiation protocols were as described above. Oil-red-
O staining was performed at day 7. Each experiment was repeated
three times.
DNA content
VAT and SCAT tissues from 29-weeks-old male mice were
homogenized with a Polytron in 1.5 ml PBS containing protease
inhibitors (Roche, Basel, Switzerland), followed by a centrifugation
at 11000 RPM for 5 minutes. The supernatant was placed in
another tube for the DNA content assay. DNA content was
measured using the Hoechst Method [15].
Statistical Analysis
Statistical analyses were performed using the Graphpad Prism
4.0 software (Graphpad Software Inc.). Comparisons between
groups were performed using the Student t-test.
Results
To evaluate the role of Plac8 in white adipogenesis we first
assessed the pattern of Plac8 expression during differentiation of
3T3-L1 adipocytes. Figure 1A shows that upon induction of
differentiation, there was a rapid and transient induction of Plac8
expression, which corresponded closely to the pattern of expres-
sion of C/EBPb and Krox20, two transcription factors required
early during white fat differentiation. ShRNA-mediated down-
expression of Plac8 reduced 3T3-L1 differentiation as determined
by Oil Red O (ORO) staining (Figure 1B); this was associated with
reduced expression of Plac8 protein and mRNA levels, as well as a
reduced expression of C/EBPb, Klf4, C/EBPd, Krox20, Pparc2 and
Ap2 (Figure 1C,D). Expression of other adipocyte-specific genes,
Ebf1, Gata3, Nur77 and cyclinD1 were, however, not affected by
Plac8 knockdown (Figure S1). With shRNA-mediated knockdown
of Plac8, addition of rosiglitazone, a potent PPARc agonist, also
failed to restore the full differentiation of 3T3-L1 cells, as shown by
ORO staining and gene expression analysis (Figure S2).
To determine whether overexpression of Plac8 could increase
differentiation, 3T3-L1 preadipocytes were transduced with Plac8-
expressing retroviruses (Figure 2). This led to increased Plac8
expression and differentiation of 3T3-L1 adipocytes as revealed by
ORO staining and by expression of C/EBPb, C/EBPd, Krox20,
PPARc2 and aP2 (Figure 2A, B, C).
As another model to assess the requirement for Plac8 to induce
adipogenesis, we established embryonic fibroblasts (MEF) from
control, Plac8+/2 and Plac82/2 mice. Differentiation of wild-type
MEF into ORO positive cells was readily achieved with the
differentiation cocktail. Differentiation of the heterozygous mutant
MEF was less efficient and almost undetectable in the knockout
MEF (Figure 3A), as also revealed by measuring expression of aP2,
PPARc2 and adiponectin. We attempted to rescue differentiation of
Plac8 knockout MEF by retroviral transduction of Plac8. However,
in the absence of Plac8, MEF proliferate extremely slowly, in
agreement with a previous report showing that knockdown of
Plac8 markedly reduces cell proliferation rate [16]. This decreased
proliferation rate prevented retrovirus-mediated gene transduc-
tion.
To get another independent assessment of the role of Plac8 in
white adipogenesis, we transduced NIH 3T3 cells with C/EBPb,
which is known to allow adipocyte differentiation in the presence
of rosiglitazone. Figure 4 shows that Plac8 by itself did not induce
significant ORO accumulation (Figure 4A) but is an inducer of C/
EBPb (Figure 4B). However, when transduced together with C/
EBPb it led to a marked increase in ORO staining and expression
of aP2, resistin, and adiponectin as compared to C/EBPb transduction
alone (Figure 4A,B).
The above data therefore indicated that Plac8 was required for
white adipogenesis in 3T3-L1 cells, MEF, and NIH 3T3 cells.
They also suggested that Plac8 was an inducer of C/EBPb
expression. This was directly tested by C/EBPb-promoter reporter
assays in transfected 3T3-L1 adipoyctes. As shown in Figure 4C,
co-transfection of Plac8 with the C/EBPb reporter construct
markedly increased luciferase activity of the reporter construct.
Mice with genetic inactivation of Plac8 develop late-onset
obesity [11]. To assess whether the obesity phenotype was
associated with defect in white adipocytes, we first performed
histological analysis of visceral and subcutaneous white fat depots.
Figure 5A, B, C shows that white adipocytes from both fat depots
from heterozygous and homozygous Plac8 knockout mice had
increased size. Weight measurements showed increased visceral
and subcutaneous fat mass in heterozygous and homozygous
knockout mice (Figure 5D). Importantly, however, the total DNA
content of these fat depots was lower in the Plac8 knockout mice
indicating that even though their mass was greater, the number of
cells forming these tissues was smaller (Figure 5E).
Gene expression analysis revealed that this was associated with
reduced expression of C/EBPb, C/EBPa, and PPARc2 in both
VAT and SCAT but no significant reduction of C/EBPd and aP2
(Figure 6A,B). These data therefore indicated that absence of Plac8
led to reduced total number of white adipocytes but enlargement
of the existing ones and reduced expression of critical adipogenic
transcription factors. Analysis of lipolytic and lipogenic gene
expression showed that, in visceral adipose tissue, the levels of Acc1
and Srebp-1c were normal but those of Fas and Scd-1 were
increased in Plac82/2 but not Plac8+/2 adipose tissue (Figure 7A).
Expression of the lipolytic genes Atgl and Hsl were, however, not
different between geneotypyes (Figure 7B). In subcutaneous fat,
there was no change in srebp-1c expression but reduced expression
of Acc1, Fas and Scd-1 and no change in Atgl and Hsl (Figure 7C,D).
Expression of the inflammatory cytokines TNFa and Il-6 was not
increased in the adipose tissue of Plac8 knockout mice (not shown).
As defect in brown fat function and obesity are often associated
with abnormal glucose homeostasis, we measured plasma glucose,
free fatty acid, and triglyceride concentrations in fed and fasted
control and Plac82/2 mice. Figure 8A, B, C show that these
parameters were indistinguishable between control and knockout
mice.
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Figure 1. Plac8 knockdown in 3T3-L1 decreases adipogenesis. A, Time-course (0, 3, and 6 h, 1 to 7 days) of Plac8, C/EBPb and Krox20 mRNA
expression during 3T3-L1 cells differentiation. Three independent experiments are shown. B, Oil red O staining of 3T3-L1 transduced with two
different Plac8 (sh1 and sh2 and a control (shLuc) shRNAs at 7 days after induction of differentiation. Upper row: culture dishes; lower row:
Plac8 in White Adipogenesis
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Discussion
This study demonstrates that Plac8 is required for in vitro white
fat adipogenesis. In vivo, however, Plac8 is dispensable for the
formation of white adipocytes but its absence leads to obesity with
apparently fewer but greatly enlarged adipocytes. The defect in
thermoregulation and increased adiposity are, however, not
photomicrographs of the cells (scale bars = 100 mm). C, Western blot analysis of Plac8 protein in shRNA-transduced 3T3-L1 cells at day 0 and 3 and
6 hours after induction of differentiation. Actin served as loading control D, mRNA levels of Plac8 and of the transcriptional regulators C/EBPb, C/EBPd,
Krox20, Klf4 and PPARc2 and of the general adipogenic gene aP2 at day 0 and 7 of differentiation. One representative experiment out of three is
shown. Values are means 6 SD, n= 3.,*p,0.05 vs. shLuc, #p,0.05 vs. shLuc at day 0.
doi:10.1371/journal.pone.0048767.g001
Figure 2. Plac8 overexpression in 3T3-L1 enhances adipogenesis. A, 3T3-L1 cells were transduced with Plac8 or control retroviruses. Oil red O
staining was performed at 7 days after induction of differentiation. Upper row: culture dishes; lower row: photomicrographs of the cells (scale
bars = 100 mm). B, Western blot analysis of Plac8 in shRNA transduced 3T3-L1 cells at day 0 and 3 and 6 hours after induction of differentiation. Actin
served as loading control C, mRNA levels of Plac8 and of the transcriptional regulators C/EBPb, C/EBPd, Krox20 and PPARc2 and of the general
adipogenic gene aP2 at days 0 and 7 of differentiation. One representative experiment out of three is shown. Values are means 6 SD, n = 3.,*p,0.05
vs. shLuc, #p,0.05 vs. shLuc at day 0.
doi:10.1371/journal.pone.0048767.g002
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associated with changes in glucose homeostasis nor in plasma free
fatty acid and triglyceride levels.
Plac8 is expressed in both white and brown fat and in both
tissues it is enriched in the stromal-vascular fraction containing
preadipocytes. General Plac8 inactivation in mice leads to a
phenotype of cold intolerance that can be explained by impaired
fat oxidation and thermogenesis by brown adipose tissue [11]. The
late-onset obesity may, however, result from combined defects in
both brown and white fat differentiation and function. Here, our
studies aimed to determine the role of Plac8 in white adipogenesis
and in white fat in Plac82/2 mice.
In vitro, absence of Plac8 expression prevented differentiation
into adipocytes of 3T3-L1 preadipocytes, of NIH 3T3 cells, and of
MEF derived from Plac82/2 mice. Kinetics analysis of transcrip-
tion factor expression upon induction of 3T3-L1 adipocytes
differentiation revealed that Plac8 expression peaked at ,3 hours,
a kinetics similar to that of Krox20 and C/EBPb expression.
Analysis of Krox20, Klf4, and C/EBPb expression in 3T3-L1 cells in
which Plac8 was knocked down showed that their expression was
reduced. In vivo, Plac82/2 visceral and subcutaneous fat tissues
showed reduced expression of C/EBPb, C/EBPa and PPARc2.
These data therefore suggested that Plac8 is an upstream regulator
of the adipogenic transcription cascade. This is in agreement with
our studies in BAT preadipocytes, which showed that Plac8 is an
upstream regulator of C/EBPb transcription [11]. This was also
confirmed by demonstrating that Plac8 activated the transcrip-
tional activity of a C/EBPb promoter reporter construct expressed
in 3T3-L1 adipocytes. Quantitative RT-PCR analysis also showed
that absence of Plac8 led to a reduced expression of Klf4 and
Krox20, two factors required early for induction of adipogenesis
Figure 3. Absence of Plac8 prevents adipogenic differentiation of primary mouse embryonic fibroblasts. A, Oil red O staining of
primary mouse embryonic fibroblasts from Plac8+/+; Plac8+/2 and Plac82/2 mice 7 days after induction of differentiation. Upper row: culture dishes;
lower row: photomicrographs of the cells (scale bars = 50 mm). B, mRNA expression of aP2, PPARc2 and adiponectin at day 0 and day 7 after induction
of differentiation. One representative experiment out of three is shown. Values are means6 SD. *p,0.05 vs. Plac8+/+ at day 7,#p,0.05 vs. Plac8+/+ at
day 0.
doi:10.1371/journal.pone.0048767.g003
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Figure 4. Plac8 increases C/EBPb-induced adipogenesis of NIH-3T3 fibroblasts. A, NIH-3T3 cells were transduced with Plac8 and C/EBPb, or
control retroviruses and Oil red O staining was performed 7 days after induction of differentiation. Upper row: culture dishes; lower row:
photomicrographs of the cells (scale bars = 50 mm). B, mRNA levels of the Plac8, C/EBPb and aP2 and of the white fat genes adiponectin and resistin at
days 0 and 7 after induction of differentiation. One representative experiment out of three is shown. Values are means6 SD, n= 4. *p,0.05 vs. Plac8+/
+ at day 7,#p,0.05 vs. Plac8+/+ at day 0, $p,0.05 vs. Plac82/2 at day 7. C, Plac8 transactivates C/EBPb and Krox20 promoters in 3T3-L1 preadipocytes.
Transcriptional activity of a 3 kb C/EBPb promoter-luciferase reporter construct (black bars) or empty vector (pGL3) (white bars, close to the zero level
and not visible) cotransfected into 3T3-L1 preadipocytes with a Plac8 expression or an empty vector. Luciferase activities were determined 48 hours
after transfection. Results are means 6 SD (n = 3), one representative experiment is shown. *p,0.05 vs. empty vector.
doi:10.1371/journal.pone.0048767.g004
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Figure 5. Adipocytes in visceral and subcutaneous adipose tissues are enlarged in Plac82/2mice. Hematoxylin-eosin staining of VAT (A)
and SCAT (B) sections of 29-weeks-old Plac8+/+, Plac8+/2 and Plac82/2 mice (scale bars = 50 mm). C, Analysis of VAT and SCAT adipocytes size
distribution of Plac8+/+, Plac8+/2 and Plac82/2mice. D, VAT and SCAT weight in Plac8+/+, Plac8+/2 and Plac82/2mice. E, Total DNA content in VAT and
SCAT of the same mice. Values are means 6 SEM (n = 7–13). *p,0.05 vs. Plac8+/+.
doi:10.1371/journal.pone.0048767.g005
Plac8 in White Adipogenesis
PLOS ONE | www.plosone.org 8 November 2012 | Volume 7 | Issue 11 | e48767
[7,8] and which acts, at least in part, through induction of C/
EBPb. Thus, Plac8 appears as an upstream regulator of
adipogenesis, acting rapidly after induction of differentiation to
trigger the adipogenic transcription cascade.
In our present studies differentiation of 3T3-L1 and NIH3T3
cells could be increased by Plac8 transduction, which ensures a
stable protein expression for periods of time that are much longer
than the transient induction seen upon induction of preadipocyte
differentiation. Because Plac8 has been reported to increase the
proliferation of certain cell types [16,17] and that adipogenic
differentiation requires growth-arrest, the adipocyte differentiation
we observed here may underestimate of the role of Plac8 since it
can induce two apparently opposed cellular effects. On the other
hand, the adipogenic function of Plac8 depends on its transient
interaction with C/EBPb, an event that immediately follows the
induction of differentiation, possibly as a result of posttranslational
modifications induced by the differentiation cocktail [11]. So far,
there is no information about Plac8 posttranslational modifica-
tions, or its interaction with posttranslational modifications of
other proteins. This information is required to fully understand
how Plac8 contributes to increased adipogenesis.
Figure 6. Adipogenic transcriptional regulators are decreased in white adipose tissues of Plac82/2 mice. mRNA levels of the
transcriptional regulators C/EBPb, C/EBPa, PPARc2, C/EBPd and of aP2 in VAT (A) and SCAT (B) of 24 weeks-old Plac8+/+, Plac8+/2 and Plac82/2 mice.
Values are means 6 SEM (n= 7–13), *p,0.05 vs. Plac8+/+.
doi:10.1371/journal.pone.0048767.g006
Plac8 in White Adipogenesis
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Plac8 is a relatively small protein consisting of 124 amino acids
containing an evolutionarily-conserved cysteine-rich domain that
directs interaction with other proteins. Because Plac8 does not
have any structural motif usually associated with transcription
factors and due to its small size, its function in adipogenesis is
probably to regulate the cellular localization, function, or stability
of other proteins, such as through its binding to C/EBPb, which is
required for the C/EBPb-Plac8 complex to bind to the C/EBPb
promoter to induce this gene transcription [11].
In vivo, Plac8 is not absolutely required for either brown or
white fat differentiation since both tissues are present in the
Plac82/2 mice. This observation is analogous to that found, for
instance with C/EBPb or Klf15. Suppressed activity of either gene
in 3T3-L1 fibroblasts prevents their adipogenic differentiation but
knockout of either gene in mice does not prevent appearance of
white fat depots [9,18,19,20]. In Plac82/2 mice absence of Plac8
leads to a decreased expression of important adipogenic genes
such as C/EBPb, C/EBPa and PPARc2 but not of other genes such
as C/EBPd and aP2. This, however, does not prevent augmented
fat storage in this tissue. Obesity is usually associated with increase
in both adipose cell number and cell size [21,22,23]. Interestingly,
in Plac82/2 mice obesity is not associated with increased cell
number but our data rather suggest a decrease in total adipocyte
number. This suggests, that even though adipogenesis during
development may proceed normally, the recruitment of new
adipocytes from preadipocytes during the adult age may be
defective even though the fat storage capacity of existing
adipocytes is preserved. This fat cell enlargement occurs in the
Figure 7. Expression of lipogenic and lipolytic genes in VAT and SCAT of Plac82/2 mice. mRNA levels of the lipogenic genes Acc1, SREBP-
1c, Fas and SCD-1, and of the lipolytic genes Atgl and Hsl in VAT (A,B) and (C,D) of 24 weeks-old Plac8+/+, Plac8+/2 and Plac82/2 mice. Values are
means 6 SEM (n = 7–13), *p,0.05 vs. Plac8+/+.
doi:10.1371/journal.pone.0048767.g007
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absence of changes in lipolytic gene expression and with an
opposite regulation of lipogenic gene expression, which were
increased in VAT (fas and scd-1) whereas these genes and acc-1
were decreased in SCAT. The meaning of this opposite regulation
is not yet clear.
Decreased BAT activity and increased white fat mass are
thought to favor deregulation of glucose homeostasis. However, in
the normal chow fed, 29 weeks-old control, Plac+/2 Plac82/2 mice
studied here fed and fasted glycemia as well as plasma free fatty
acids and triglycerides were indistinguishable. This, therefore,
suggest that in the conditions studied the defects in thermoregu-
lation and increased white fat mass were not causing major
deregulation of glucose homeostasis. We cannot, however, exclude
the presence of subtle deregulations in glucose or lipid metabolism,
which would require more detailed analysis.
In summary, our data show that Plac8 is required for in vitro
adipogenesis and functions upstream of C/EBPb and possibly
Krox20 and Klf4 in triggering adipogenesis. In vivo, Plac8 is
dispensable for the production of WAT and BAT. However,
because there are fewer white adipocytes in Plac82/2 mice, this
suggests that the recruitment of new adipocytes during adult life
may be impaired and that the phenotype of the Plac82/2 mice
depends on complex interactions between defects in both white
and brown adipose tissues.
Supporting Information
Figure S1 Plac8 knockdown in 3T3-L1 decreases adipo-
genesis. mRNA levels of the transcriptional regulators Ebf1,
Gata2, Gata3, Nur77 and of Cyclin D1 during differentiation of Plac8
shRNA1 and 2 and control transduced 3T3-L1 cells at day 0 and
7. One representative experiment out of three is shown. Values are
means 6 SD, n= 3,*p,0.05 vs. shLuc, #p,0.05 vs. shLuc at day
0
(TIF)
Figure S2 Rosiglitazone does not restore the full adipo-
genic phenotype in shRNA expressing 3T3-L1 cells. A, Oil
red O staining of 3T3-L1 transduced with two different shRNA
against Plac8 or the control shRNA (shLuc) at 7 days after
induction of differentiation in the presence of rosiglitazone in the
differentiation cocktail. Upper row: culture dishes; lower row:
photomicrographs of the cells (scale bars = 100 mm). B, mRNA
levels aP2 and PPARc2 during at day 0 and 7 of differentiation.
One representative experiment out of three is shown. Values are
means 6 SD, n= 3.,*p,0.05 vs. shLuc, #p,0.05 vs. shLuc at day
0.
(TIF)
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Figure 8. Normal glycemia and plasma free fatty acids and triglycerides in Plac82/2 mice. Blood glucose (A), and plasma free fatty acids
(FFA) (B) and triglycerides (C) levels in fed and 16-hours fasted Plac8+/+ and Plac82/2 24-weeks old mice Values are means6 SEM (n= 7–13), *p,0.05
vs. Plac8+/+ at fed state.
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